To include your compound in the COVID-19 Resource Center, submit it here.

Oric raises $53 million series B

Oric Pharmaceuticals Inc. (South San Francisco, Calif.) raised $53

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE